References

Are serum uric acid levels predictors of cardiovascular risk?

10.1097/hco.0000000000001029 · 2023 · External reference

Association of hyperuricemia with risk of cardiovascular disease according to the number of risk factors within target range

10.1016/j.numecd.2024.07.011 · 2024 · External reference

Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid

10.1177/2047487320957793 · 2020 · External reference

Uric acid in metabolic and cerebrovascular disorders: A review

10.2174/1570161118666191217123930 · 2020 · External reference

Uric Acid and Hypertension: a Review of Evidence and Future Perspectives for the Management of Cardiovascular Risk

10.1161/hypertensionaha.122.17956 · 2022 · External reference

Clinical Feature-Based Machine Learning Model for 1-Year Mortality Risk Prediction of ST-Segment Elevation Myocardial Infarction in Patients with Hyperuricemia

10.1155/2021/7252280 · 2021 · External reference

Gout and hyperuricaemia: Modifiable cardiovascular risk factors?

10.3389/fcvm.2023.1190069 · 2023 · External reference

A systematic review of the connection between serum uric acid levels and the risk of cardiovascular disease

2025 · External reference

Progress of uric acid in cardiovascular disease

2024 · External reference

Minimal clinically important difference: Bridging the gap between statistical significance and clinical meaningfulness

10.1016/j.jclinane.2023.111366 · 2024 · External reference

The misunderstood P-value: Why statistical significance is not enough in clinical practice

10.1016/j.bja.2025.01.008 · 2025 · External reference

Commentary: Statistical significance and clinical significance - A call to consider patient reported outcome measures, effect size, confidence interval and minimal clinically important difference (MCID)

10.1016/j.jbmt.2019.02.009 · 2019 · External reference